Issue |
E3S Web Conf.
Volume 509, 2024
2nd International Conference on Sustainable Nanotechnology & Nanomaterials (ICONN-2023)
|
|
---|---|---|
Article Number | 02003 | |
Number of page(s) | 15 | |
Section | Nanobiotechnology and Biological Applications | |
DOI | https://doi.org/10.1051/e3sconf/202450902003 | |
Published online | 08 April 2024 |
Brassica oleracea var.acephala of kashmir as a promising candidate for improvement of lipid profile associated with hyperglycemia through in vivo study in male albino rats
University Institute of Biotechnology, Chandigarh University, Gharuan, Mohali, Punjab 140413
Diabetes mellitus commonly considered as clandestine killer is a metabolic disorder that affects people all over the world and is a silent killer. A variety of treatments are available, including insulin and oral anti-diabetic medications for regulating blood sugar levels in the body but every treatment option has certain unfavorable side effects that might cause abnormalities with the macro and microvascular systems in the human body. Kale (Brassica oleracea var. acephala) from the brassica family is gaining popularity due to its phytochemical content and ability to prevent many ailments, notably those brought on by oxidative stress. The current study assessed Brassica oleracea var acephala of the UT of Kashmir locally known as khanyari as it is loaded with various bioactive substances including total phenols, flavonoids, and glucosinolates that impart antioxidant and antidiabetic properties. Kale(K-29) showed impressive results in normalizing the blood glucose levels(102.30mg/dl) as well as improving the lipid profile such as cholesterol(76.22mg/dl), HDL(36.4mg/dl), LDL(36.1mg/dl), VLDL(21.2mg/dl) and triglycerides(85.40mg/dl) that is usually accompanied with hyperglycemia. The treatment of K-29 also showed improvisation in the various hepatic parameters such as S.G.P.T(91.14), S.G.O.T (41.18), Alkaline phosphatase (102.32U/L), Albumin (6.12g/dl), S. bilirubin direct(0.6mg/dl), S. bilirubin indirect(0.43mg/dl).
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.